Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Soeiro‐de‐Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate Jr CA, Machado‐Vieira R. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Objective: Bipolar disorder (BD) likely involves, at a molecular and cellular level, dysfunctions of critical neurotrophic, cellular plasticity and resilience pathways and neuroprotective processes. Therapeutic properties of mood stabilizers are presumed to result from a restoration of the function of these altered pathways and processes through a wide range of biochemical and molecular effects. We aimed to review the altered pathways and processes implicated in BD, such as neurotrophic factors, mitogen‐activated protein kinases, Bcl‐2, phosphoinositol signaling, intracellular calcium and glycogen synthase kinase‐3. Methods: We undertook a literature search of recent relevant journal articles, book chapter and reviews on neurodegeneration and neuroprotection in BD. Search words entered were ‘brain‐derived neurotrophic factor,’‘Bcl‐2,’‘mitogen‐activated protein kinases,’‘neuroprotection,’‘calcium,’‘bipolar disorder,’‘mania,’ and ‘depression.’ Results: The most consistent and replicated findings in the pathophysiology of BD may be classified as follows: i) calcium dysregulation, ii) mitochondrial/endoplasmic reticulum dysfunction, iii) glial and neuronal death/atrophy and iv) loss of neurotrophic/plasticity effects in brain areas critically involved in mood regulation. In addition, the evidence supports that treatment with mood stabilizers; in particular, lithium restores these pathophysiological changes. Conclusion: Bipolar disorder is associated with impairments in neurotrophic, cellular plasticity and resilience pathways as well as in neuroprotective processes. The evidence supports that treatment with mood stabilizers, in particular lithium, restores these pathophysiological changes. Studies that attempt to prevent (intervene before the onset of the molecular and cellular changes), treat (minimize severity of these deficits over time), and rectify (reverse molecular and cellular deficits) are promising therapeutic strategies for developing improved treatments for bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
New insights into BDNF function in depression and anxiety
Martinowich, K., Manji, H., & Lu, B. (2007) · Nature Neuroscience · doi:10.1038/nn1971 · Cited by 1,221 · cited 15×
“Chronic antidepressant treatment increases BDNF expression in rat prefrontal cortex and hippocampus (74).”
BackgroundInfluentialBDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
Bramham, C. R., & Messaoudi, E. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.003 · Cited by 1,193
Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression
Drevets, W. C. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26027-5 · Cited by 659 · cited 1×
“Consistent with neurotrophic ⁄neuroprotective properties of lithium and valproate, patients treated with chronic lithium or valproate exhibited subgenual PFC volumes that were significantly greater than non-treated patients, and not significantly different from controls (22).”
BackgroundLithium-induced increase in human brain grey matter
Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Menji, H. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02793-8 · Cited by 649 · cited 2×
“(23, 24) observed elevated N-acetyl-aspartate (NAA) (a mitochondrial marker of neuronal integrity) levels and gray matter volume in lithium-treated subjects.”
BackgroundAndreazza, A. C., Shao, L., Wang, J.-F., & Young, L. T. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.22 · Cited by 448
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264 · cited 2×
“Although the cause of white matter hyperintensities in mood disorders is unknown, their presence particularly in the brains of young patients with BD suggests that importance in the pathophysiology of the illness (17, 18).”
BackgroundBaumann, B., Danos, P., Krell, D., Diekmann, S., Leschinger, A., Stauch, R., Wurthmann, C., Bernstein, H.-G., & Bogerts, B. (1999) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.11.1.71 · Cited by 198 · cited 2×
“In postmortem brain studies, reduced subcortical nuclei volumes in BD has been reported (19, 20).”
BackgroundThe expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia
Benes, F. M., Matzilevich, D., Burke, R. E., & Walsh, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001758 · Cited by 183 · cited 1×
“BD (17, 18, 52, 53), as well as a significant increase in the number of proapoptotic genes in hippocampus from BD subjects (19, 20, 52).”
BackgroundBrain-derived neurotrophic factor and neuroplasticity in bipolar disorder
Kapczinski, F., Frey, B. N., Kauer-Sant’Anna, M., & Grassi-Oliveira, R. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1101 · Cited by 181
Cited by
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Mood disorders in the elderly: prevalence, functional impact, and management challenges
Forlenza, O. V., Valiengo, L., & Stella, F. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s94643 · Cited by 129
“Therefore, one may hypothesize that persistent and progressive cognitive deterioration in BD reflects the long-time outcome of the disease, presumably sharing mechanisms of cognitive decline with other major psychiatric disorders.(64)”
Self-citationBarbosa, I. G., Rocha, N. P., Assis, F., Vieira, E. L. M., Soares, J. C., Bauer, M. E., & Teixeira (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu021 · Cited by 101
A five‐year follow‐up study of neurocognitive functioning in bipolar disorder
Santos, J. L., Aparicio, A., Bagney, A., Sánchez‐Morla, E. M., Rodríguez‐Jiménez, R., Mateo, J., & Jiménez‐Arriero, M. Á. (2014) · Bipolar Disorders · doi:10.1111/bdi.12215 · Cited by 93
Neonatal levels of neurotrophic factors and risk of autism spectrum disorders
Abdallah, M. W., Mortensen, E. L., Greaves‐Lord, K., Larsen, N., Bonefeld‐Jørgensen, E. C., Nørgaard‐Pedersen, B., Hougaard, D. M., & Grove, J. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12020 · Cited by 72
“The potential role of NTFs in the pathophysiology of several psychiatric disorders such as bipolar disorders (13), depression (14), schizophrenia (10) as well as obsessive–compulsive disorders has been the focus of many studies (15, 16).”
Background
Metadata
- Authors
- Soeiro‐de‐Souza, M. G., Dias, V. V., Figueira, M. L., Forlenza, O. V., Gattaz, W. F., Zarate, C. A., & Machado‐Vieira, R.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2012-06-08
- Volume
- 126
- Issue
- 5
- Pages
- 332-341
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2133111244
- Cited by
- 72
- References
- 13
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. https://app.cochat.ai/papers/10.1111/j.1600-0447.2012.01889.x
- The paper
- Soeiro‐de‐Souza, M. G., Dias, V. V., Figueira, M. L., Forlenza, O. V., Gattaz, W. F., Zarate, C. A., & Machado‐Vieira, R. (2012). Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.2012.01889.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.